We harness the powerful capabilities of Patient Derived Tumoroids (PDTs) to accelerate the drug development process for solid tumor cancers.
Our platform uniquely creates stable tumor models that are biobanked for rapid deployment and enables reproducible studies.
We maintain an intact and functional tumor microenvironment (TME) for therapeutic discoverers and developers whose studies require robust and faithful preclinical research models. Our unique 3D tumor models enable the recapitulation of patient-specific tumor-immune interactions to fast-track the search for novel cures and bring hope to millions of patients.
Tumoroids are the perfectly optimized human tool for performing:
biomarker discovery
drug selection & ratios for more informed treatment decisions
assessment of combination therapies
drug rescue & repurposing
search for predictive signatures of drug failure, toxicity and response
derisking clinical trials
testing within the platform to facilitate precision cancer immunotherapy
Company Details
- Employees
- 2
- Address
- 2450 Holcombe Blvd, Houston,texas 77021,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.spanioslab.com
- Keywords
- Designer jobs.
- HQ
- Houston, Texas
Spanios Questions
Spanios's website is http://www.spanioslab.com
Spanios's LinkedIn profile is https://www.linkedin.com/company/spanios
Spanios has
2 employees.
View email and phone details for 2
employees at Spanios.
Spanios's industry is
Biotechnology Research
Spanios's top competitors are
Cellenkos, Inc.,
Portal Innovations,
Inaphaea Biolabs,
Phiogen,
March Biosciences,
Biohouston,
Alpharose Therapeutics,
Ctrl Therapeutics,
Fannin,
Orphan Therapeutics Accelerator.
Spanios's categories are Biotechnology Research
